COGENT BIOSCIENCES INC COM is a security (CUSIP 19240Q201) tracked across SEC portfolio filings. 311 institutional managers reported $6.8B on Form 13F as of 2026-06-30; 44 registered fund positions totaling $205.8M via N-PORT as of 2026-06-30.
Showing 15 of 311 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| FMR LLC | BOSTON, MA | $890.0M | 23,122,748 |
| BlackRock, Inc. | New York, NY | $617.6M | 16,045,014 |
| VANGUARD GROUP INC | Valley Forge, PA | $409.0M | 11,514,326 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | New York, NY | $348.1M | 9,043,903 |
| JANUS HENDERSON GROUP PLC | LONDON, X0 | $229.6M | 5,965,125 |
| STATE STREET CORP | BOSTON, MA | $218.0M | 5,663,543 |
| Fairmount Funds Management LLC | WEST CONSHOHOCKEN, PA | $211.8M | 5,503,418 |
| RTW INVESTMENTS, LP | NEW YORK, NY | $210.1M | 5,458,675 |
| TCG Crossover Management, LLC | PALO ALTO, CA | $190.4M | 4,946,894 |
| GOLDMAN SACHS GROUP INC | NEW YORK, NY | $170.7M | 4,434,054 |
| Kynam Capital Management, LP | PRINCETON, NJ | $155.4M | 4,037,331 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $142.4M | 3,699,519 |
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $137.7M | 3,578,622 |
| COMMODORE CAPITAL LP | NEW YORK, NY | $111.2M | 2,888,007 |
| Pictet Asset Management Holding SA | CAROUGE, V8 | $92.6M | 2,393,515 |
Showing 15 of 44 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $37.4M | 29.26% |
| Fidelity Balanced Fund | Fidelity Puritan Trust | $25.1M | 3.81% |
| LORD ABBETT DEVELOPING GROWTH FUND INC | LORD ABBETT DEVELOPING GROWTH FUND, INC. | $23.7M | 106.94% |
| Fidelity Fund | Fidelity Hastings Street Trust | $18.4M | 21.87% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $12.6M | 11.53% |
| VANGUARD HEALTH CARE INDEX FUND | VANGUARD WORLD FUND | $8.8M | 4.65% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $8.8M | 18.26% |
| Fidelity Series Total Market Index Fund | Fidelity Concord Street Trust | $8.2M | 0.73% |
| Lord Abbett Growth Opportunities Fund | LORD ABBETT RESEARCH FUND INC | $7.6M | 95.35% |
| abrdn Healthcare Investors | abrdn Healthcare Investors | $6.7M | 59.19% |
| VANGUARD EXPLORER FUND | VANGUARD EXPLORER FUND | $5.9M | 2.73% |
| VIP Stock Selector Portfolio | Variable Insurance Products Fund | $5.9M | 13.00% |
| BlackRock Health Sciences Term Trust | BlackRock Health Sciences Term Trust | $5.3M | 52.71% |
| abrdn Life Sciences Investors | abrdn Life Sciences Investors | $3.8M | 67.17% |
| Schwab U.S. Broad Market ETF | SCHWAB STRATEGIC TRUST | $3.2M | 0.75% |